|
|
|
Volumn 65, Issue 11-12, 1981, Pages 1127-1129
|
|
Concomitant phase II studies of pyrazofurin and razoxane in alkylating agent-resistant cases of epithelial ovarian carcinoma
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
MELPHALAN;
PIRAZOFURIN;
RAZOXANE;
THIOTEPA;
ADVERSE DRUG REACTION;
ALOPECIA;
BLADDER;
BLOOD AND HEMOPOIETIC SYSTEM;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE GENITAL SYSTEM;
HEMORRHAGIC CYSTITIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MOUTH;
MUCOSA INFLAMMATION;
NAUSEA;
OVARY CANCER;
OVARY CARCINOMA;
RANDOMIZED CONTROLLED TRIAL;
STOMATITIS;
THERAPY;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMAN;
LEUKOPENIA;
MIDDLE AGE;
NAUSEA;
OVARIAN NEOPLASMS;
PIPERAZINES;
RAZOXANE;
RIBONUCLEOSIDES;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0019769958
PISSN: 03615960
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|